Pediatric cancer relapse prediction is becoming a pivotal focus in modern oncology, particularly with advancements in artificial intelligence (AI) technology.A groundbreaking study has demonstrated that AI tools can significantly enhance the prediction of relapse risk in children diagnosed with brain tumors, specifically gliomas.